Ann Thorac Surg

1. ALVARADO CE, Worrell SG
   Pathologic Response is Negatively Impacted by Diabetes for Esophageal Cancer.
   Ann Thorac Surg. 2024 Apr 9:S0003-4975(24)00258.
   

   >> Share

   
   

   
   BMC Cancer

2. AWNY S, Abdallah A, Metwally IH, Abdelwahab K, et al
   Impact of age on central lymph nodes involvement in papillary thyroid cancer.
   BMC Cancer. 2024;24:423.
   

   >> Share

   
   
3. WANG H, Zhang C, Li Q, Tian T, et al
   Development and validation of prediction models for papillary thyroid cancer structural recurrence using machine learning approaches.
   BMC Cancer. 2024;24:427.
   

   >> Share

   
   
4. CIRILLO A, Marinelli D, Romeo U, Messineo D, et al
   Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
   BMC Cancer. 2024;24:430.
   

   >> Share

   
   
5. CAO X, Wang X, Song J, Su Y, et al
   Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma.
   BMC Cancer. 2024;24:435.
   

   >> Share

   
   
6. ROUTILA E, Mahran R, Salminen S, Irjala H, et al
   Identification of stemness-related glycosylation changes in head and neck squamous cell carcinoma.
   BMC Cancer. 2024;24:443.
   

   >> Share

   
   
7. DEUTSCH F, Sais D, Keatinge N, Hill M, et al
   Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva.
   BMC Cancer. 2024;24:442.
   

   >> Share

   
   

   
   Clin Nucl Med

8. KUMAR SA, Mittal BR, Kumar S, Singh H, et al
   FDG PET/CT in the Diagnosis and After Sunitinib Follow-up of Synchronous Base of Tongue and Thyroid Metastases From Renal Cell Carcinoma.
   Clin Nucl Med. 2024;49:e208-e210.
   

   >> Share

   
   
9. AK SIVRIKOZ I, Deveci H, Yildirim N
   A Rare False-Positive Whole-Body Scan in a Patient With Differentiated Thyroid Cancer: Unilateral Conjunctival Concretions.
   Clin Nucl Med. 2024;49:451-453.
   

   >> Share

   
   
10. VERMA P, Malhotra G, Rao RD, Sonavane S, et al
    Rare Presentations of Differentiated Thyroid Cancer Exposing Dr Jekyll and Mr Hyde Nature of an Otherwise Indolent Disease: Case Series.
    Clin Nucl Med. 2024 Feb 27. doi: 10.1097/RLU.0000000000005138.
    

    >> Share

    
    
11. TSUKAMOTO S, Kawabata K, Kawamura H, Takata K, et al
    Differentiating Brown Tumor From Bone Metastasis in Parathyroid Cancer Using 18F-FDG PET and 99mTc-MIBI SPECT.
    Clin Nucl Med. 2024 Feb 23. doi: 10.1097/RLU.0000000000005115.
    

    >> Share

    
    

    
    Dis Esophagus

12. JEON YJ, Han K, Lee SW, Lee JE, et al
    Metabolic dysfunction-associated steatotic liver disease and risk of esophageal cancer in patients with diabetes mellitus: a nationwide cohort study.
    Dis Esophagus. 2024 Apr 8:doae029. doi: 10.1093.
    

    >> Share

    
    

    
    Head Neck

13. DONG YJ, Zhang HH, Liang JQ, Gao YY, et al
    Laryngeal paraganglioma: The analysis of misdiagnosed cases and literature review.
    Head Neck. 2024;46:1234-1247.
    

    >> Share

    
    
14. LI Y, Guan X, Xing X, Hu C, et al
    Survival outcomes and toxicity profiles among patients with nonmetastatic nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT) versus IMRT + carbon-ion radiotherapy: A propensity score-matched analysis.
    Head Neck. 2024 Apr 9. doi: 10.1002/hed.27771.
    

    >> Share

    
    
15. BECKER AS, Merkel J, Bozkurt I, Struder DF, et al
    p16 overexpression identifies oncogenic high-risk HPV infection in non-oropharyngeal squamous cell carcinoma of the head and neck.
    Head Neck. 2024 Apr 9. doi: 10.1002/hed.27764.
    

    >> Share

    
    
16. LIEM X, de Baere T, Vivar OI, Seiwert TY, et al
    International guidelines for intratumoral and intranodal injection of NBTXR3 nanoparticles in head and neck cancers.
    Head Neck. 2024 Apr 10. doi: 10.1002/hed.27739.
    

    >> Share

    
    
17. PRASAD K, Peterson N, Nolen D, Macharia C, et al
    Building a sustainable free flap program in a resource-limited setting: A 12-year humanitarian effort.
    Head Neck. 2024;46:1051-1055.
    

    >> Share

    
    
18. FENG Y, Qian K, Guo K, Shi Y, et al
    Effectiveness and risk of second primary malignancies after radiotherapy in major salivary gland carcinomas: A retrospective study using SEER database.
    Head Neck. 2024;46:1201-1209.
    

    >> Share

    
    
19. GAIFFE O, Mahdjoub J, Ramasso E, Mauvais O, et al
    Discrimination of vocal folds lesions by multiclass classification using autofluorescence spectroscopy: An ex vivo study.
    Head Neck. 2024;46:1136-1145.
    

    >> Share

    
    
20. WANG A, Xiao N, Wang H, Yao Q, et al
    Development of a novel senescence-related gene signature to predict clinical outcomes, immune landscape, and chemotherapeutic sensitivity in oral squamous cell carcinoma.
    Head Neck. 2024;46:1112-1125.
    

    >> Share

    
    
21. STARMER HM, Patterson J, Young B, Fleming J, et al
    Development of a head and neck lymphoedema specific quality of life tool: The Comprehensive Assessment of Lymphoedema Impact in the Head and Neck.
    Head Neck. 2024;46:1103-1111.
    

    >> Share

    
    
22. LIAO J, Yang Z, Azarbarzin S, Cullen KJ, et al
    Differential modulation of PI3K/Akt/mTOR activity by EGFR inhibitors: A rationale for co-targeting EGFR and PI3K in cisplatin-resistant HNSCC.
    Head Neck. 2024;46:1126-1135.
    

    >> Share

    
    
23. LIN SY, Li MY, Zhou CP, Ao W, et al
    Accurate preoperative prediction of nodal metastasis in papillary thyroid microcarcinoma: Towards optimal management of patients.
    Head Neck. 2024;46:1009-1019.
    

    >> Share

    
    
24. TABARI A, Nasirmohtaram S, Mohammadi HR, Zeinalizadeh M, et al
    Anterior endoscopic sublabial transmaxillary access to middle cranial base lesions.
    Head Neck. 2024;46:1028-1042.
    

    >> Share

    
    
25. KIMURA TC, Scarini JF, Lavareze L, Kowalski LP, et al
    MicroRNA copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
    Head Neck. 2024;46:985-1000.
    

    >> Share

    
    
26. STRUCKMEIER AK, Buchbender M, Lutz R, Agaimy A, et al
    Comparison of the prognostic value of lymph node yield, lymph node ratio, and number of lymph node metastases in patients with oral squamous cell carcinoma.
    Head Neck. 2024;46:1083-1093.
    

    >> Share

    
    
27. WISTERMAYER PR, Brown AE, Cave TB, Chang BA, et al
    Effect of palatine tonsil tumor resection on postoperative velopharyngeal insufficiency in transoral surgery.
    Head Neck. 2024;46:1178-1188.
    

    >> Share

    
    
28. HONG SA, Armstrong AT, Snow K, Walker RJ, et al
    Association of adjuvant radiation and survival in human papilloma virus-positive oropharynx squamous cell carcinoma with lymphovascular invasion as the sole adverse pathologic feature.
    Head Neck. 2024;46:1043-1050.
    

    >> Share

    
    

    
    Histopathology

29. HEMPENIUS MA, Koomen BM, Deckers IAG, Oosting SF, et al
    Considerable interlaboratory variation in PD-L1 positivity for head and neck squamous cell carcinoma in the Netherlands- A nationwide evaluation study.
    Histopathology. 2024 Apr 12. doi: 10.1111/his.15184.
    

    >> Share

    
    

    
    Int J Cancer

30. DI W, Yu J, Zong D, Ge Y, et al
    Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China.
    Int J Cancer. 2024 Apr 10. doi: 10.1002/ijc.34933.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

31. SMITH J, Margalit D, Golledge J, Nastasi D, et al
    Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00474.
    

    >> Share

    
    

    
    Laryngoscope

32. YANG P, Jiang J
    In Reference to Evaluation of Oropharyngeal Cancer Information from Revolutionary Artificial Intelligence Chatbot.
    Laryngoscope. 2024;134:E18.
    

    >> Share

    
    
33. KOKOT NC, Davis RJ
    In Response to Evaluation of Oropharyngeal Cancer Information from Revolutionary Artificial Intelligence Chatbot.
    Laryngoscope. 2024;134:E19.
    

    >> Share

    
    
34. DAVIS RJ, Ayo-Ajibola O, Lin ME, Swanson MS, et al
    Evaluation of Oropharyngeal Cancer Information from Revolutionary Artificial Intelligence Chatbot.
    Laryngoscope. 2024;134:2252-2257.
    

    >> Share

    
    
35. FESTA BM, Costantino A, Pace GM, Petruzzi G, et al
    Impact of Adjuvant Radiotherapy in Squamous Cell Carcinoma of the Oral Cavity with Perineural Invasion.
    Laryngoscope. 2024;134:2019-2027.
    

    >> Share

    
    
36. CAREY RM, Prasad A, Wei K, Brant JA, et al
    Primary Site Surgery in Distantly Metastatic Oropharyngeal Squamous Cell Carcinoma.
    Laryngoscope. 2024;134:2243-2251.
    

    >> Share

    
    
37. VINCIGUERRA A, Atallah S, Boaria F, Molher J, et al
    Septal Nasopharyngeal "Kite Flap" for Long-Term Patency of Petrous Apex Cholesterol Granuloma.
    Laryngoscope. 2024;134:2111-2114.
    

    >> Share

    
    
38. LACCOURREYE O, Garcia D, Haroun F, Nguyen DH, et al
    Primary Total Laryngectomy for Endolaryngeal cT3-4M0 Squamous Cell Carcinoma: A STROBE Analysis.
    Laryngoscope. 2024;134:2288-2294.
    

    >> Share

    
    
39. WARSHAVSKY A, Rubin R, Carmel-Neidermann NN, Brenner A, et al
    4DCT in Discordant Parathyroid Adenoma Scans: Case Series and Meta-Analysis.
    Laryngoscope. 2024;134:2198-2205.
    

    >> Share

    
    
40. RAAD RA, Akers R, Al-Khudari S, Stenson K, et al
    A Nationwide Analysis of Head and Neck Fibromatoses.
    Laryngoscope. 2024;134:2228-2235.
    

    >> Share

    
    
41. WANG RS, Chow MS, Gordon AJ, Santacatterina M, et al
    Adjuvant Radiotherapy in Moderately Advanced (T3) Oral Cavity Cancers.
    Laryngoscope. 2024;134:2236-2242.
    

    >> Share

    
    
42. VOS DJ, Arianpour K, Fritz MA, Hadford S, et al
    Minimally Invasive Approach to Access Vessels for Microvascular Anastomosis in Head and Neck Reconstruction.
    Laryngoscope. 2024;134:2177-2181.
    

    >> Share

    
    

    
    Oral Oncol

43. RAJAKUMAR HK, Coimbatore Sathyabal V, Vivekanandam A, Nasrin Jabarulla K, et al
    Evaluation of nuclear morphometry in exfoliative cytology of buccal mucosa in patients with high risk of oral cancer.
    Oral Oncol. 2024;152:106793.
    

    >> Share

    
    
44. SIVAPERUMAL P, Ganapathy D, Kamala K
    Revolutionizing oral cancer treatment: Harnessing the potential of adaptive CARneg T cell therapy.
    Oral Oncol. 2024;152:106794.
    

    >> Share

    
    
45. SEGNA E, Civita F, Denaro N, Beltramini GA, et al
    Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer.
    Oral Oncol. 2024;152:106784.
    

    >> Share

    
    
46. KONO M, Saito S, Rokugo M, Egloff AM, et al
    Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer.
    Oral Oncol. 2024;152:106795.
    

    >> Share

    
    
47. HUNG CY, Lee TL, Chang CW, Wang CP, et al
    Margin to depth of invasion ratio as an indicator for stratifying close margins in early-stage oral squamous cell carcinoma.
    Oral Oncol. 2024;151:106726.
    

    >> Share

    
    
48. FARAH CS, Shearston K, Turner EC, Vacher M, et al
    Global gene expression profile of proliferative verrucous leukoplakia and its underlying biological disease mechanisms.
    Oral Oncol. 2024;151:106737.
    

    >> Share

    
    
49. MELACHURI M, Kurukulasuriya C, Rumde P, Patel T, et al
    Treatment package time < 14 weeks improves recurrence free and disease specific survival in HPV positive OPC with high-risk features.
    Oral Oncol. 2024;151:106703.
    

    >> Share

    
    
50. MIRIMOGHADDAM M, Bohlouli B, Lai H, Viegas S, et al
    Trends and predictors of unplanned hospitalization among oral and oropharyngeal cancer patients; an 8-year population-based study.
    Oral Oncol. 2024;151:106742.
    

    >> Share

    
    
51. KANG CJ, Lee LY, Ng SH, Lin CY, et al
    Should sub-millimeter margins be deemed positive in oral cavity squamous cell carcinoma?
    Oral Oncol. 2024;151:106745.
    

    >> Share

    
    
52. MALI SB
    Role of telemedicine in head neck cancer.
    Oral Oncol. 2024;151:106746.
    

    >> Share

    
    
53. FERRARO T, Pershad AR, Arora S, Lee E, et al
    The utility of ultrasonographic surveillance in management of a presumed branchial cleft cyst later confirmed HPV-associated oropharyngeal cancer.
    Oral Oncol. 2024;151:106743.
    

    >> Share

    
    
54. ZUPANCIC M, Kostopoulou ON, Holzhauser S, Lukoseviciute M, et al
    Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
    Oral Oncol. 2024;151:106749.
    

    >> Share

    
    
55. GASNE C, Atallah S, Dauzier E, Thariat J, et al
    Twelve years after: The french national network on rare head and neck tumours (REFCOR).
    Oral Oncol. 2024;151:106762.
    

    >> Share

    
    
56. MAUCERI R, Coppini M, Perez-Sayans M, Toro C, et al
    Challenges in the diagnosis of oral squamous cell carcinoma mimicking medication-related osteonecrosis of the jaws: a multi-hospital-based case series.
    Oral Oncol. 2024;151:106689.
    

    >> Share

    
    
57. HUANG J, Fehr A, Jawert F, Nilsson JA, et al
    MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
    Oral Oncol. 2024;151:106763.
    

    >> Share

    
    
58. MIGLIARI D
    Does a biopsy improve the diagnosis of oral lichen planus and management of the patient? In which scenario does the malignant transformation matter most?
    Oral Oncol. 2024;151:106764.
    

    >> Share

    
    
59. HUA Y, Ma P, Li C, Gao N, et al
    Association between COVID 19 exposure and expression of malignant pathological features in oral squamous cell carcinoma: A retrospective cohort study.
    Oral Oncol. 2024;151:106740.
    

    >> Share

    
    
60. MORIWAKI K, Ayani Y, Kuwabara H, Terada T, et al
    Differential expression of TRKB tyrosine kinase in the two histological types of parotid salivary duct carcinoma with cancer aggressiveness.
    Oral Oncol. 2024;151:106751.
    

    >> Share

    
    

    
    Otolaryngol Head Neck Surg

61. TOPKAN E, Somay E, Selek U
    Causes of Delays in Starting Postoperative Radiotherapy Among Head and Neck Cancer Patients.
    Otolaryngol Head Neck Surg. 2024 Apr 12. doi: 10.1002.
    

    >> Share

    
    
62. LELE SJ, Adilbay D, Lewis E, Pang J, et al
    ctDNA as an Adjunct to Posttreatment PET for Head and Neck Cancer Recurrence Risk Assessment.
    Otolaryngol Head Neck Surg. 2024 Apr 9. doi: 10.1002.
    

    >> Share

    
    
63. MARTIN J, Hans S, Ferris RL, Baudouin R, et al
    Over 132 Years Ago, the Inaugural Immunotherapy Treated Its First Head and Neck Cancer Patient.
    Otolaryngol Head Neck Surg. 2024 Apr 8. doi: 10.1002.
    

    >> Share

    
    

    
    PLoS One

64. RUSANEN P, Marttila E, Amatya SB, Hagstrom J, et al
    Expression of Toll-like receptors in oral squamous cell carcinoma.
    PLoS One. 2024;19:e0300437.
    

    >> Share

    
    

    
    Radiother Oncol

65. SHUANG H, Feng J, Caineng C, Qifeng J, et al
    Long-term efficacy analysis of radiotherapy and local management of metastases in patients with newly diagnosed oligometastatic nasopharyngeal carcinoma: A prospective, single-arm, single-center clinical study.
    Radiother Oncol. 2024 Apr 5:110265. doi: 10.1016/j.radonc.2024.110265.
    

    >> Share

    
    

    
    Surgery

66. MA S, Zhu J, Xue M, Shen Y, et al
    Early postoperative endoscopy for predicting anastomotic leakage after minimally invasive esophagectomy: A large-volume retrospective study.
    Surgery. 2024;175:1305-1311.
    

    >> Share

    
    
67. LUNARDI N, Jacob A, Elfenbein D, Schneider DF, et al
    Don't chase the adenoma: A probabilistic approach to imaging before parathyroidectomy.
    Surgery. 2024;175:1299-1304.
    

    >> Share

    
    

    
    Thyroid

68. TAHARA M, Kiyota N, Imai H, Takahashi S, et al
    A phase II study of encorafenib in combination with binimetinib in patients with metastatic BRAF-mutated thyroid cancer in Japan.
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0547.
    

    >> Share

    
    
69. BROCK P, Liyanarachchi S, Nieminen TT, Chan C, et al
    CHEK2 founder variants and thyroid cancer risk.
    Thyroid. 2024 Jan 27. doi: 10.1089/thy.2023.0529.
    

    >> Share

    
    
70. SHIRAI YT, Hoshi N, Ward JM, Liu H, et al
    Establishment and characterization of amitrole-induced mouse thyroid adenomatous nodule-derived cell lines.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0341.
    

    >> Share

    
    
71. CHENG SY, Kimura T, Doolittle WKL, Kruhlak M, et al
    Inhibition of MEK signaling attenuates cancer stem cell activity in anaplastic thyroid cancer.
    Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0521.
    

    >> Share

    
    
72. ASSAAD S, Dov D, Park C, Davis R, et al
    A preliminary study comparing the performance of thyroid molecular tests to a deep learning algorithm in predicting malignancy in indeterminate thyroid fine needle aspiration biopsies.
    Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0054.
    

    >> Share

    
    
73. ESPINOSA DE YCAZA AE, Brito JP, McCoy R, Shao H, et al
    GLP-1 receptor agonists and thyroid cancer: a narrative review.
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0530.
    

    >> Share

    
    
74. FERNANDEZ-VELASCO P, Perez Lopez P, Torres B, Delgado E, et al
    Clinical evaluation of an Artificial Intelligence-based decision support system for the diagnosis and ACR TI-RADS classification of thyroid nodules.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2023.0603.
    

    >> Share

    
    
75. SFREDDO HJ, Koh ES, Zhao K, Swartzwelder CE, et al
    RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance.
    Thyroid. 2024 Feb 26. doi: 10.1089/thy.2023.0544.
    

    >> Share

    
    
76. STILLMAN M, Kuo EJ, Liou R, Almuqate A, et al
    Molecular Testing for Bethesda III Thyroid nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution.
    Thyroid. 2024 Mar 12. doi: 10.1089/thy.2023.0664.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share